1. ACT UP . 2002 . “ Accelerating “Access” Serves Pharmaceutical Companies While Corrupting Health Organizations ” . Paris Press statement 15 May. Available at: http://www.actupny.org/reports/Durban-accessPR.html (last accessed 27 February 2012)
2. Policy Making on Data Exclusivity in the European Union: From Industrial Interests to Legal Realities
3. Alexander , J. 2008 . “ SPIC Urges Govt to Safeguard Export Business of SME Units While Reframing Counterfeit Definition ” . PharmBiz . New Delhi. Available at: http://saffron.pharmabiz.com/article/detnews.asp?Arch=a&articleid=47069§ionid=19 (last accessed: 27 February 2012).
4. Confusion over counterfeit drugs in Uganda